29 August 2025

HSBC BANK PLC

WITHDRAWAL OF LISTING OF ZERO COUPON CALLABLE ACCRETING NOTES DUE SEPTEMBER 27, 2042 (CUSIP: 40442B2A4) FROM THE NEW YORK STOCK EXCHANGE

HSBC Bank plc ("HBEU" or the "Company") announces that it intends to delist its Zero Coupon Callable Accreting Notes due September 27, 2042 (CUSIP: 40442B2A4) (the "Notes") from the New York Stock Exchange ("NYSE").

HBEU will provide written notice to the NYSE of its intent to delist.

The main purpose of delisting is to simplify HBEU's reporting obligations, as part of HBEU's plan to demise its programme for the issuance of debt securities registered with the U.S. Securities and Exchange Commission (the "SEC").

HBEU intends to submit an application to Euronext Dublin for the Notes to be admitted to trading on the Global Exchange Market of Euronext Dublin, which is an existing listing venue for HBEU's structured notes issued under its non-U.S. Notes and Warrants Programme.

HBEU plans to file the related Form 25 with the SEC around 10 days after the date hereof and expects the delisting to become effective ten days after such filing.

HBEU will continue to be registered under the U.S. Securities Exchange Act of 1934 (the "Exchange Act") for the time being, and the Company will continue to comply with its obligations under the Exchange Act. Once the delisting has become effective and the Company meets the criteria for terminating its reporting obligations under the Exchange Act, it intends to file Form 15 with the SEC in order to deregister all classes of its registered securities.

Immediately upon filing Form 15 HBEU's legal obligation to file reports under the Exchange Act will be suspended, and deregistration is expected to become effective 90 days later.

HBEU reserves the right, for any reason, to delay these filings or to withdraw them prior to their effectiveness, and to otherwise change its plans in this regard.

ends/more

Investor enquiries to:
Greg Case                    +44 (0) 20 7992 3825                 [email protected]

Media enquiries to:

Press Office                 +44 (0) 20 7991 8096                 [email protected]

ends/all